Redcell Path Labs Private Limited
About Redcell Path Labs Private Limited
Data last updated:
Redcell Path Labs Private Limited is a private limited company based in Delhi, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 20 April 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2017PTC316408.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Ankur Panwar and Vikas Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 50 Gali No. 1 Kundan Nagar Laxmi Nagar, Delhi, India – 110092.
As per the financials filed for FY 2025, the company reported a revenue of ₹47.88 Lakh, a growth of 21% compared to the previous year. For the same year it recorded a net profit of ₹52,793 (net margin 1.1%) and EBITDA of ₹3.11 Lakh (EBITDA margin 6.5%). Revenue has grown at a compounded annual rate (CAGR) of 38% over three years and 33% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address50 Gali No. 1 Kundan Nagar Laxmi Nagar, Delhi, India – 110092
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Redcell Path Labs Private Limited
The main business activity of Redcell Path Labs is hospital and medical care. In detail, this covers medical and dental practice, nursing, pathology, blood bank services, etc..
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q2 | Medical and dental practice, Nursing, pathology, blood bank services, etc. | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Redcell Path Labs Private Limited FY 2025 filings available
Redcell Path Labs Private Limited reported revenue of ₹47.88 Lakh (up 21% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Redcell Path Labs Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 33% over five years, including 21% growth in the latest year. EBITDA rose 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Redcell Path Labs Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹3.11 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹52,793 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Redcell Path Labs Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Redcell Path Labs are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Redcell Path Labs Private Limited
Redcell Path Labs has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ankur Panwar | Director | 20 Apr 2017 | 9 Years 5 Months | Current |
| Vikas Kumar | Director | 20 Apr 2017 | 9 Years 5 Months | Current |
| Pradeep Kumar Gangwar | Additional Director | 05 Apr 2025 | 1 Years 6 Months | Current |
Ownership and Shareholding of Redcell Path Labs Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Redcell Path Labs Private Limited
Redcell Path Labs Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Redcell Path Labs Private Limited
Employment history and EPFO contributions of people linked to Redcell Path Labs.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Redcell Path Labs Private Limited
Redcell Path Labs Private Limited has 4 board changes on record since 2017: 3 appointments and 1 cessation. The latest: Pradeep Kumar Gangwar was appointed as Additional Director on 05 Apr 2025.
Credit Ratings, Litigation & Regulatory Alerts for Redcell Path Labs Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Redcell Path Labs Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Redcell Path Labs Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Redcell Path Labs Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Redcell Path Labs Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Redcell Path Labs Private Limited
Redcell Path Labs is an active private limited company based in Delhi, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 20 April 2017 (9+ years old) and is registered under CIN U74999DL2017PTC316408.
Redcell Path Labs reported revenue of ₹47.88 Lakh for FY 2025 (up 21% YoY).
Redcell Path Labs has 3 current directors:
- Ankur Panwar - Director
- Vikas Kumar - Director
- Pradeep Kumar Gangwar - Additional Director
Redcell Path Labs reported a net profit of ₹52,793 (net margin 1.1%) and EBITDA of ₹3.11 Lakh (EBITDA margin 6.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Redcell Path Labs is 38% over three years and 33% over five years. In the latest year (FY 2025) revenue rose 21%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Redcell Path Labs is U74999DL2017PTC316408. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Redcell Path Labs was incorporated on 20 April 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
Pradeep Kumar Gangwar was appointed as Additional Director on 05 Apr 2025. Vikas Kumar ceased to be Director on 05 Apr 2025. Ankur Panwar was appointed as Director on 20 Apr 2017. Redcell Path Labs has 4 board changes on record in total.
The registered office of Redcell Path Labs is at 50 Gali No. 1 Kundan Nagar Laxmi Nagar, Delhi, India – 110092.
Redcell Path Labs has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.